Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2017

Open Access 01-04-2017 | Epidemiology

Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers

Authors: Marc B.I. Lobbes, Ingeborg J.H. Vriens, Annelotte C.M. van Bommel, Grard A.P. Nieuwenhuijzen, Marjolein L. Smidt, Liesbeth J. Boersma, Thijs van Dalen, Carolien Smorenburg, Henk Struikmans, Sabine Siesling, Adri C. Voogd, Vivianne C.G. Tjan-Heijnen

Published in: Breast Cancer Research and Treatment | Issue 2/2017

Login to get access

Abstract

Purpose

In this retrospective population-based cohort study, we analyzed breast MRI use and its impact on type of surgery, surgical margin involvement, and the diagnosis of contralateral breast cancer.

Methods

All Dutch patients with cT1–4N0–3M0 breast cancer diagnosed in 2011–2013 and treated with primary surgery were eligible for inclusion. Using multivariable analyses, we analyzed in different categories whether MRI use was related to surgery type, margin involvement, and diagnosis of contralateral breast cancer (CBC).

Results

MRI was performed in 10,740 out of 36,050 patients (29.8%). Patients with invasive ductal cancer undergoing MRI were more likely to undergo primary mastectomy than those without MRI (OR 1.30, 95% confidence interval (CI) 1.22–1.39, p < 0.0001). Patients with invasive lobular cancer undergoing MRI were less likely to undergo primary mastectomy than those without MRI (OR 0.86, 95% CI 0.76–0.99, p = 0.0303). A significantly lower risk of positive surgical margins after breast-conserving surgery was only seen in patients with lobular cancer who had undergone MRI as compared to those without MRI (OR 0.59, 95% CI 0.44–0.79, p = 0.0003) and, consequently, a lower risk of secondary mastectomy (OR 0.61, 95% CI 0.42–0.88, p = 0.0088). Patients who underwent MRI were almost four times more likely to be diagnosed with CBC (OR 3.55, 95% CI 3.01–4.17, p < 0.0001).

Conclusions

Breast MRI use was associated with a reduced number of mastectomies and less positive surgical margins in invasive lobular cancer, but with an increased number of mastectomies in ductal cancers. Breast MRI use was associated with a fourfold higher incidence of CBC.
Literature
1.
go back to reference Gruber IV, Rueckert M, Kagan KO et al (2013) Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer. BMC Cancer 13:328CrossRefPubMedPubMedCentral Gruber IV, Rueckert M, Kagan KO et al (2013) Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer. BMC Cancer 13:328CrossRefPubMedPubMedCentral
2.
go back to reference Medeiros LR, Duarte CS, Rosa DD et al (2011) Accuracy of magnetic resonance in suspicious breast lesions: a systematic quantitative review and meta-analysis. Breast Cancer Res Treat 126:273–285CrossRefPubMed Medeiros LR, Duarte CS, Rosa DD et al (2011) Accuracy of magnetic resonance in suspicious breast lesions: a systematic quantitative review and meta-analysis. Breast Cancer Res Treat 126:273–285CrossRefPubMed
4.
go back to reference National Breast Cancer Organization of the Netherlands (2012) National guideline breast cancer 2012. NABON, Amsterdam National Breast Cancer Organization of the Netherlands (2012) National guideline breast cancer 2012. NABON, Amsterdam
5.
go back to reference Houssami N, Turner R, Morrow M (2013) Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg 257:249–255CrossRefPubMed Houssami N, Turner R, Morrow M (2013) Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg 257:249–255CrossRefPubMed
6.
go back to reference Fancellu A, Turner RM, Dixon JM, Pinna A, Cottu P, Houssami N (2015) Meta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ. Br J Surg 102:883–893CrossRefPubMed Fancellu A, Turner RM, Dixon JM, Pinna A, Cottu P, Houssami N (2015) Meta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ. Br J Surg 102:883–893CrossRefPubMed
7.
go back to reference Van Bommel AC, Spronk PE, Vrancken-Peeters MT, et al (2016) Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit. J Surg Oncol Van Bommel AC, Spronk PE, Vrancken-Peeters MT, et al (2016) Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit. J Surg Oncol
8.
go back to reference Gombos EC, Jayender J, Richman DM et al (2016) Intraoperative supine breast MR imaging to quantify tumor deformation and detection of residual breast cancer: preliminary results. Radiology 281:720–729CrossRefPubMed Gombos EC, Jayender J, Richman DM et al (2016) Intraoperative supine breast MR imaging to quantify tumor deformation and detection of residual breast cancer: preliminary results. Radiology 281:720–729CrossRefPubMed
10.
go back to reference Oliveira TMG, Elias J Jr, Melo AF et al (2014) Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods. Insights Imaging 5:183–194CrossRefPubMedPubMedCentral Oliveira TMG, Elias J Jr, Melo AF et al (2014) Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods. Insights Imaging 5:183–194CrossRefPubMedPubMedCentral
11.
go back to reference Van den Broek N, Van der Sangen MJC, Van de Poll-Franse LV, Van Beek MWPM, Nieuwenhuijzen GAP, Voogd AC (2007) Margin status and the risk of local recurrence after breast-conserving therapy of lobular breast cancer. Breast Cancer Res Treat 105:63–68CrossRefPubMed Van den Broek N, Van der Sangen MJC, Van de Poll-Franse LV, Van Beek MWPM, Nieuwenhuijzen GAP, Voogd AC (2007) Margin status and the risk of local recurrence after breast-conserving therapy of lobular breast cancer. Breast Cancer Res Treat 105:63–68CrossRefPubMed
12.
go back to reference Wanis ML, Wong JA, Rodriguez S et al (2013) Rate of re-excision after breast-conserving surgery for invasive lobular carcinoma. Am Surg 79:1119–1122PubMed Wanis ML, Wong JA, Rodriguez S et al (2013) Rate of re-excision after breast-conserving surgery for invasive lobular carcinoma. Am Surg 79:1119–1122PubMed
13.
go back to reference Biglia N, Maggiorotto F, Liberale V et al (2013) Clinical-pathological features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). Eur J Surg Oncol 39:455–460CrossRefPubMed Biglia N, Maggiorotto F, Liberale V et al (2013) Clinical-pathological features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). Eur J Surg Oncol 39:455–460CrossRefPubMed
14.
go back to reference Braunstein LZ, Brock JE, Chen YH et al (2015) Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin. Breast Cancer Res Treat 149:555–564CrossRefPubMed Braunstein LZ, Brock JE, Chen YH et al (2015) Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin. Breast Cancer Res Treat 149:555–564CrossRefPubMed
15.
go back to reference Arps DP, Jorns JM, Zhao L, Bensenhaver J, Kleer CG, Pang JC (2014) Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast. Ann Surg Oncol 21:4152–4158CrossRefPubMed Arps DP, Jorns JM, Zhao L, Bensenhaver J, Kleer CG, Pang JC (2014) Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast. Ann Surg Oncol 21:4152–4158CrossRefPubMed
16.
go back to reference Mann RM, Loo CE, Wobbes T et al (2010) The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 119:415–422CrossRefPubMed Mann RM, Loo CE, Wobbes T et al (2010) The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 119:415–422CrossRefPubMed
17.
go back to reference McGhan LJ, Wasif N, Gray RJ et al (2010) Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best? Ann Surg Oncol 17:S255–S262CrossRef McGhan LJ, Wasif N, Gray RJ et al (2010) Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best? Ann Surg Oncol 17:S255–S262CrossRef
18.
go back to reference Heil J, Buhler A, Golatta M et al (2011) Does a supplementary preoperative breast MRI in patients with invasive lobular breast cancer change primary and secondary surgical interventions? Ann Surg Oncol 18:2143–2149CrossRefPubMed Heil J, Buhler A, Golatta M et al (2011) Does a supplementary preoperative breast MRI in patients with invasive lobular breast cancer change primary and secondary surgical interventions? Ann Surg Oncol 18:2143–2149CrossRefPubMed
19.
go back to reference Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomized controlled trial. Lancet 375:563–571CrossRefPubMed Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomized controlled trial. Lancet 375:563–571CrossRefPubMed
20.
go back to reference Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46:1296–1316CrossRefPubMed Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46:1296–1316CrossRefPubMed
22.
go back to reference Lehman CD, Gatsonis C, Kuhl CK et al (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295–1303CrossRefPubMed Lehman CD, Gatsonis C, Kuhl CK et al (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295–1303CrossRefPubMed
23.
go back to reference Liberman L, Morris EA, Kim CM et al (2003) MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. Am J Roentgenol 180:333–341CrossRef Liberman L, Morris EA, Kim CM et al (2003) MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. Am J Roentgenol 180:333–341CrossRef
24.
go back to reference Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW (2009) Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol 20:1505–1510CrossRefPubMed Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW (2009) Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol 20:1505–1510CrossRefPubMed
25.
go back to reference Schaapveld M, Visser O, Louwman WJ et al (2008) The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat 110:189–197CrossRefPubMed Schaapveld M, Visser O, Louwman WJ et al (2008) The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat 110:189–197CrossRefPubMed
26.
go back to reference Reding KW, Bernstein JL, Langholz BM et al (2010) Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat 123:491–498CrossRefPubMedPubMedCentral Reding KW, Bernstein JL, Langholz BM et al (2010) Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat 123:491–498CrossRefPubMedPubMedCentral
27.
go back to reference De Glas NA, Engels CC, Bastiaannet E et al (2015) Contralateral breast cancer risk in relation to tumor morphology and age: in which patients is preoperative MRI justified? Breast Cancer Res Treat 150:191–198CrossRefPubMedPubMedCentral De Glas NA, Engels CC, Bastiaannet E et al (2015) Contralateral breast cancer risk in relation to tumor morphology and age: in which patients is preoperative MRI justified? Breast Cancer Res Treat 150:191–198CrossRefPubMedPubMedCentral
28.
go back to reference Chae EY, Shin HJ, Kim HJ et al (2013) Diagnostic performance of automated breast ultrasound as a replacement for a hand-held second-look ultrasound for breast lesions initially detected on magnetic resonance imaging. Ultrasound Med Biol 12:2246–2254CrossRef Chae EY, Shin HJ, Kim HJ et al (2013) Diagnostic performance of automated breast ultrasound as a replacement for a hand-held second-look ultrasound for breast lesions initially detected on magnetic resonance imaging. Ultrasound Med Biol 12:2246–2254CrossRef
29.
go back to reference Mariscotti G, Houssami N, Durando M et al (2015) Digital breast tomosynthesis (DBT) to characterize MRI-detected additional lesions unidentified at targeted ultrasound in newly diagnosed breast cancer patients. Eur Radiol 25:2673–2681CrossRefPubMed Mariscotti G, Houssami N, Durando M et al (2015) Digital breast tomosynthesis (DBT) to characterize MRI-detected additional lesions unidentified at targeted ultrasound in newly diagnosed breast cancer patients. Eur Radiol 25:2673–2681CrossRefPubMed
30.
go back to reference Lobbes MB, Lalji UC, Nelemans PJ et al (2015) The quality of tumor size assessment by contrast-enhanced spectral mammography and the benefit of additional breast MRI. J Cancer 6:144–150CrossRefPubMedPubMedCentral Lobbes MB, Lalji UC, Nelemans PJ et al (2015) The quality of tumor size assessment by contrast-enhanced spectral mammography and the benefit of additional breast MRI. J Cancer 6:144–150CrossRefPubMedPubMedCentral
31.
go back to reference Trimboli RM, Di Leo G, Sacchetto D et al (2016) The impact of breast MRI on surgical planning and reoperation rate: first results from the MIPA study. Insights Imaging 7:S464 Trimboli RM, Di Leo G, Sacchetto D et al (2016) The impact of breast MRI on surgical planning and reoperation rate: first results from the MIPA study. Insights Imaging 7:S464
32.
go back to reference Houssami N, Turner R, Macaskill P et al (2014) An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. J Clin Oncol 32:392–401CrossRefPubMed Houssami N, Turner R, Macaskill P et al (2014) An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. J Clin Oncol 32:392–401CrossRefPubMed
Metadata
Title
Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers
Authors
Marc B.I. Lobbes
Ingeborg J.H. Vriens
Annelotte C.M. van Bommel
Grard A.P. Nieuwenhuijzen
Marjolein L. Smidt
Liesbeth J. Boersma
Thijs van Dalen
Carolien Smorenburg
Henk Struikmans
Sabine Siesling
Adri C. Voogd
Vivianne C.G. Tjan-Heijnen
Publication date
01-04-2017
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2017
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4117-8

Other articles of this Issue 2/2017

Breast Cancer Research and Treatment 2/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine